Effects of Physical Activity on the Brain in Parkinson's Disease (PD)
NCT ID: NCT01741584
Last Updated: 2016-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Training Induced Plasticity of Motor Control Mechanisms in Parkinson's Disease Patients
NCT03753503
Impact of Exercise in Parkinson's Disease
NCT03495193
Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease
NCT00748488
Physical Activity in Patients With Parkinson's Disease: a "Disease Modifying" Intervention?
NCT05815524
Exploring the Effects of Exercise on Memory and Cognition in Parkinson´s Disease
NCT06580977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stationary bike exercise
6 months of exercise (60% of anaerobic threshold)
stationary bike exercise
aerobic
6 months of exercise \<30% anaerobic threshold
aerobic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stationary bike exercise
aerobic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* L-DOPA responsive
* \<5 yrs since diagnosis
Exclusion Criteria
* MMSE \< 26
* treatment with psychiatric medication
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agnes Flöel
Prof. Dr. med. Agnes Floeel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Agnes Flöel, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology, Charité Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PA_memory_01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.